Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

deCODE genetics, Inc.

Hakon Hakonarson1, Jeffrey R Gulcher, Kari Stefansson

  • 1deCODE genetics, Inc., Sturlugata 8, IS-101 Reykjavik, Iceland. hakonh@decode.is

Pharmacogenomics
|February 28, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The copy number variation landscape of congenital anomalies of the kidney and urinary tract.

Nature genetics·2018
Same author

NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses.

Brain : a journal of neurology·2018
Same author

Cryptic intronic NBAS variant reveals the genetic basis of recurrent liver failure in a child.

Molecular genetics and metabolism·2018
Same author

Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.

Nature genetics·2018
Same author

Phenotypic spectrum associated with SPECC1L pathogenic variants: new families and critical review of the nosology of Teebi, Opitz GBBB, and Baraitser-Winter syndromes.

European journal of medical genetics·2018
Same author

Unfolding of hidden white blood cell count phenotypes for gene discovery using latent class mixed modeling.

Genes and immunity·2018

deCODE genetics utilizes comprehensive population data to identify genes linked to diseases and drug response. This enables the development of personalized medicine through DNA-based diagnostics and pharmacogenomic tests.

Area of Science:

  • Genetics
  • Pharmacogenomics
  • Personalized Medicine

Background:

  • deCODE genetics possesses extensive population data, including genealogy, genotypes, and phenotypes.
  • This data facilitates the identification of genes associated with common diseases and drug response.
  • The company has a successful track record in gene mapping for complex diseases.

Purpose of the Study:

  • To identify key genes linked to common diseases.
  • To understand the genetic regulation of drug response.
  • To develop predictive tests for individual drug responsiveness.

Main Methods:

  • Utilizing a comprehensive genealogical database of the Icelandic population.
  • Conducting population- and genome-wide linkage studies.

Related Experiment Videos

  • Combining linkage analysis with high-throughput expression profiling for pharmacogenomics.

    • Main Results:

    • Successfully mapped genes in over 25 common complex diseases.
    • Isolated specific genes in eight of these diseases.
    • Developed accurate tests for predicting individual drug responsiveness.

    Conclusions:

    • The integrated approach effectively identifies genetic factors for diseases and drug response.
    • Pharmacogenomic tests are crucial for personalized medicine.
    • This strategy supports the development of more effective diagnostics and treatments by matching patients with suitable drugs.